Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.48 |
| ▸ | NPY1R | P25929 | 9/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.48 |
| ▸ | NPY2R | P49146 | 5/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30272464 | 0.92 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30786580 | 0.91 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29896074 | 0.91 | NPY4R (0.49) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30786583 | 0.89 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29576011 | 0.89 | OPRD1 (0.49) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL29420510 | 0.89 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2ROPRM1 | |
| SCHEMBL30946719 | 0.88 | NPY4R (0.50) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31752209 | 0.87 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30661263 | 0.87 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL3138301 | 0.87 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240316170-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Limited (GB) | 2024-09-26 | — | — | US | disclosed |
| EP-4236994-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Ltd. (GB) | 2023-09-06 | — | — | EP | disclosed |
| CN-116406284-A | Polypeptides for cancer treatment | 牛津疫苗医学公司 | 2023-07-07 | — | — | CN | disclosed |
| WO-2022090679-A1 | CORONAVIRUS POLYPEPTIDE | Oxford Vacmedix UK Limited (GB) | 2022-05-05 | — | — | WO | disclosed |
| WO-2022090716-A1 | POLYPEPTIDES FOR CANCER TREATMENT | Oxford Vacmedix UK Limited (GB) | 2022-05-05 | — | — | WO | disclosed |